Mounjaro (Tirzepatide) Pre-filled Injection Pen

Mounjaro (Tirzepatide) Pre-filled Injection Pen is a prescription dual GIP and GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is supplied as a sterile pre-filled injection pen for convenient once-weekly subcutaneous administration. The long-acting formulation provides accurate, reliable, and consistent dose delivery to support effective long-term treatment.

BUY NOW

Category

Mounjaro (Tirzepatide) Pre-filled Injection Pen contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps improve glycemic control by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The sterile pre-filled injection pen is engineered for precise once-weekly subcutaneous administration and is available in multiple dosage strengths to support individualized treatment plans. Manufactured under stringent pharmaceutical quality standards, the ready-to-use injection pen delivers dependable clinical performance while ensuring convenient and accurate medication delivery. Mounjaro (Tirzepatide) Pre-filled Injection Pen should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro (Tirzepatide) Pre-filled Injection Pen
Active Ingredient Tirzepatide
Dosage Form Sterile Pre-filled Injection Pen
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly (As Prescribed)
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Mounjaro Pre-filled Injection Pen, Tirzepatide Pre-filled Pen, Mounjaro Injection Pen, Tirzepatide Injection Pen, Weekly Tirzepatide Injection, Dual GIP GLP-1 Injection Pen, Diabetes Injection Pen